Neuropharmacology & Neurotherapeutics
Rotigotine
Jul. 29, 2021
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
In an E1cB (Elimination Unimolecular conjugate Base) elimination reaction, 2 substituents are removed (“elimination”) from a single molecule (“unimolecular,” as the rate-determining step involves one molecular entity) via a carbanion intermediate (the “conjugate base” of the starting material). An E1cB elimination reaction occurs under basic conditions, where a particularly poor leaving group (such as -OH or -OR) and an acidic hydrogen are removed to form an additional bond. E1cB is a two-step process. First, a base abstracts the most acidic proton to generate a stabilized anion. The lone pair of electrons on the anion then moves to the neighboring atom, expelling the leaving group and usually forming a double bond. (Courtesy of Wikimedia Commons. The Creative Commons Attribution-ShareAlike 3.0 Unported License.)